Nima Farzan's Net Worth
$0
Who is Nima Farzan?
Nima Farzan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., and Kinnate Biopharma Inc..
SEC CIK
Nima Farzan's CIK is 0001808296
Past Insider Trading and Trends
2023 was Nima Farzan's most active year for acquiring shares with 3 total transactions. Nima Farzan's most active month to acquire stocks was the month of January. 2023 saw Nima Farzan paying a total of $0.00 for 1,510,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Keros Therapeutics, Inc. (KROS) Snapshot price: $51.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.35
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.19K |
—
|
—
|
0
|
Apr 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |